Prochieve (Progesterone Vaginal 8% Gel) and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Prochieve (Progesterone Vaginal 8% Gel) and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: progesterone
Brand name: Crinone, Endometrin, FIRST-Progesterone VGS 200, Prochieve, First Progesterone MC10, Menopause Formula Progesterone, Prometrium
Synonyms: Prochieve
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Prochieve (Progesterone Vaginal 8% Gel)-Tilia Fe
- Prochieve (Progesterone Vaginal 8% Gel)-Tiludronate
- Prochieve (Progesterone Vaginal 8% Gel)-Timentin
- Prochieve (Progesterone Vaginal 8% Gel)-Timentin Add-Vantage
- Prochieve (Progesterone Vaginal 8% Gel)-Timentin Injection
- Prochieve (Progesterone Vaginal 8% Gel)-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Prochlorperazine
- Tildrakizumab-asmn Subcutaneous-Prochlorperazine Edisylate
- Tildrakizumab-asmn Subcutaneous-Prochlorperazine Injection
- Tildrakizumab-asmn Subcutaneous-Prochlorperazine Maleate
- Tildrakizumab-asmn Subcutaneous-Prochlorperazine rectal
- Tildrakizumab-asmn Subcutaneous-Prochlorperazine Suppositories